RecruitingNot ApplicableNCT04987073
Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency
Preclinic Evaluation of a Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency
Sponsor
University Hospital, Caen
Enrollment
30 participants
Start Date
Jul 17, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
Preclinical evaluation of a vitamin D analog for the treatment of vitamin D 24-hydroxylase using fibroblast from patients with CYP24A1 mutation.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a procedure called skin biopsy for people with idiopathic infantile hypercalcemia - severe form. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREskin biopsy
A skin biopsy to cultivate fibroblasts.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04987073